Literature DB >> 26058787

Benzodiazepines may reduce the effectiveness of ketamine in the treatment of depression.

Nick Ford1, Guy Ludbrook2, Cherrie Galletly3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26058787     DOI： 10.1177/0004867415590631

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN： 0004-8674            Impact factor:   5.744


× No keyword cloud information.
  6 in total

Review 1.  Use of repeated intravenous ketamine therapy in treatment-resistant bipolar depression with suicidal behaviour: a case report from Spain.

Authors:  Álvaro López-Díaz; José Luis Fernández-González; José Evaristo Luján-Jiménez; Sara Galiano-Rus; Luis Gutiérrez-Rojas
Journal:  Ther Adv Psychopharmacol       Date:  2017-01-01

Review 2.  Retracing our steps to understand ketamine in depression: A focused review of hypothesized mechanisms of action.

Authors:  Madison N Irwin; Amy VandenBerg
Journal:  Ment Health Clin       Date:  2021-05-12

3.  Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers.

Authors:  Dmitriy Matveychuk; Rejish K Thomas; Jennifer Swainson; Atul Khullar; Mary-Anne MacKay; Glen B Baker; Serdar M Dursun
Journal:  Ther Adv Psychopharmacol       Date:  2020-05-11

Review 4.  Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder.

Authors:  Brittany A Jaso; Mark J Niciu; Nicolas D Iadarola; Niall Lally; Erica M Richards; Minkyung Park; Elizabeth D Ballard; Allison C Nugent; Rodrigo Machado-Vieira; Carlos A Zarate
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

5.  Effect of Concomitant Benzodiazepine Use on Efficacy and Safety of Esketamine Nasal Spray in Patients with Major Depressive Disorder and Acute Suicidal Ideation or Behavior: Pooled Randomized, Controlled Trials.

Authors:  Bettina Diekamp; Stephane Borentain; Dong-Jing Fu; Robert Murray; Kristin Heerlein; Qiaoyi Zhang; Cornelius Schüle; Maju Mathews
Journal:  Neuropsychiatr Dis Treat       Date:  2021-07-15       Impact factor: 2.570

6.  Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review.

Authors:  Jolien K E Veraart; Sanne Y Smith-Apeldoorn; Iris M Bakker; Berber A E Visser; Jeanine Kamphuis; Robert A Schoevers; Daan J Touw
Journal:  Int J Neuropsychopharmacol       Date:  2021-10-23       Impact factor: 5.176
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.